Relay Other Non Cash Items from 2010 to 2025
| RLAY Stock | USD 2.86 0.10 3.38% |
Other Non Cash Items | First Reported 2019-03-31 | Previous Quarter 20.1 M | Current Value -2.3 M | Quarterly Volatility 28.5 M |
Check Relay Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Relay Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 36.5 M, Interest Income of 36.5 M or Depreciation And Amortization of 4.3 M, as well as many indicators such as Price To Sales Ratio of 55.88, Dividend Yield of 0.0 or PTB Ratio of 0.94. Relay financial statements analysis is a perfect complement when working with Relay Therapeutics Valuation or Volatility modules.
Relay | Other Non Cash Items |
Latest Relay Therapeutics' Other Non Cash Items Growth Pattern
Below is the plot of the Other Non Cash Items of Relay Therapeutics over the last few years. It is Relay Therapeutics' Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Relay Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Other Non Cash Items | 10 Years Trend |
|
Other Non Cash Items |
| Timeline |
Relay Other Non Cash Items Regression Statistics
| Arithmetic Mean | 6,862,334 | |
| Geometric Mean | 137,321 | |
| Coefficient Of Variation | 513.42 | |
| Mean Deviation | 16,353,583 | |
| Median | 9,000 | |
| Standard Deviation | 35,232,766 | |
| Sample Variance | 1241.3T | |
| Range | 154.9M | |
| R-Value | 0.14 | |
| Mean Square Error | 1303.8T | |
| R-Squared | 0.02 | |
| Significance | 0.60 | |
| Slope | 1,038,474 | |
| Total Sum of Squares | 18620.2T |
Relay Other Non Cash Items History
About Relay Therapeutics Financial Statements
Relay Therapeutics investors use historical fundamental indicators, such as Relay Therapeutics' Other Non Cash Items, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Relay Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Non Cash Items | 1.3 M | 1.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Relay Stock Analysis
When running Relay Therapeutics' price analysis, check to measure Relay Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relay Therapeutics is operating at the current time. Most of Relay Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relay Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relay Therapeutics' price. Additionally, you may evaluate how the addition of Relay Therapeutics to your portfolios can decrease your overall portfolio volatility.